XBiotech Inc
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation, and True Human COVID-19 therapy for treating the COVID-19 mutant virus. The company was incorporated in 2005 and is headquartered in Austin, Texas. Show More...
-
Website https://www.xbiotech.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 2.44 EUR
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -0.48 -0.31 -0.68 -1.22 -1.63 -0.95 -0.59 14.44 14.6 Dividends USD Payout Ratio % * Shares Mil 32.0 32.0 32.0 31.0 32.0 35.0 36.0 46.0 46.0 Book Value Per Share * EUR 3.23 2.08 1.59 1.14 1.39 10.92 Free Cash Flow Per Share * EUR -0.95 -1.74 -1.03 -0.47 -0.47 Return on Assets % -179.01 -101.6 -59.31 -43.7 -59.82 -50.99 -39.39 155.27 338.77 Financial Leverage (Average) 1.15 1.08 1.05 1.06 1.14 1.05 1.07 1.08 1.03 Return on Equity % -205.64 -112.81 -62.73 -46.25 -65.09 -55.61 -41.63 167.78 351.23 Return on Invested Capital % -205.66 -112.81 -62.74 -46.25 -65.15 -56.2 -42.41 167.65 350.08 Interest Coverage Current Ratio 4.09 9.1 18.45 14.79 4.64 11.94 5.78 11.9 25.2 Quick Ratio 3.91 8.57 18.21 14.47 4.31 11.38 5.37 11.87 24.92 Debt/Equity